Grand Island — Grand Island, Nebraska

Grand Island is a clinical research site located in Grand Island, Nebraska, United States 68803-4327.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Grand Island has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Uterine Fibroids, Endometriosis.

Sponsors: Sumitomo Pharma Switzerland GmbH.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Grand Island?

Grand Island has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Grand Island conducted?

Grand Island has 1 clinical trials on record, with 1 currently active. Their work covers Uterine Fibroids, Endometriosis.

Is Grand Island accredited by Crixeo Health?

Grand Island has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Grand Island?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.